NCT00004404已完成不适用
Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 20
- 试验地点
- 4
研究概览
简要总结
OBJECTIVES:
Determine the effectiveness of the combined use of clotrimazole and hydroxyurea on a specific panel of red cell characteristics in patients with sickle cell syndromes.
详细描述
PROTOCOL OUTLINE:
Patients receive oral hydroxyurea either once or twice daily plus oral clotrimazole twice daily after meals for 6 months. Patients are assessed at 3 and 6 months during treatment.
Completion date provided represents the completion date of the grant per OOPD records
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (4)
Loading locations...
相似试验
已完成
1 期
Phase I/II Randomized Study of Hydroxyurea With or Without Clotrimazole in Patients With Sickle Cell AnemiaSickle Cell AnemiaNCT00004492University of North Carolina20
已完成
2 期
Hydroxy Urea, Omega 3, Nigella Sativa,Honey on Oxidative Stress and Iron Chelation in Pediatric Major ThalassemiaIron OverloadOxidative StressThalassemia MajorNCT04292314Beni-Suef University350
已完成
2 期
Combination Therapy of Hydroxyurea With L-Carnitine and Magnesium Chloride in Thalassemia Intermediaβ-Thalassemia IntermediaNCT00809042Shiraz University of Medical Sciences120
已完成
2 期
Clinical Experience of Thalidomide in Thalassemic PatientsThalassemia, BetaNCT05132270Children's Hospital Karachi135
已完成
3 期
Multicenter Study of Hydroxyurea in Patients With Sickle Cell Anemia (MSH)Anemia, Sickle CellHematologic DiseasesHemoglobinopathiesNCT00000586National Heart, Lung, and Blood Institute (NHLBI)